As of June 20, 2025, Nanorepro AG's estimated intrinsic value ranges from $31.94 to $50.95 per share, depending on the valuation methodology applied.
| Valuation Method | Fair Value (USD) | Implied Upside/Downside |
|---|---|---|
| Discounted Cash Flow (10Y) | $50.95 | +2988.1% |
| Discounted Cash Flow (5Y) | $44.79 | +2614.6% |
| Dividend Discount Model (Multi-Stage) | $33.15 | +1909.0% |
| Dividend Discount Model (Stable) | $31.94 | +1836.0% |
| Earnings Power Value | $37.35 | +2163.5% |
Is Nanorepro AG (NN6.DE) undervalued or overvalued?
With the current market price at $1.65, the stock appears to be significantly undervalued.
Intrinsic value represents the "true" worth of a company based on its fundamentals rather than market sentiment. We've employed multiple methodologies to triangulate Nanorepro AG's intrinsic value, including:
The cost of capital is a critical factor in valuation models, representing the required return for investors.
| WACC Component | Low | High |
|---|---|---|
| Long-term bond rate | 1.1% | 1.6% |
| Equity market risk premium | 4.7% | 5.7% |
| Adjusted beta | 1.01 | 1.19 |
| Cost of equity | 5.9% | 8.9% |
| Cost of debt | 4.0% | 4.5% |
| Tax rate | 7.3% | 16.6% |
| Debt/Equity ratio | 0 | 0 |
| After-tax WACC | 5.9% | 8.9% |
Our DCF model projects cash flows over 5-year and 10-year horizons, with the following key assumptions:
| DCF Model | Fair Value | Enterprise Value | % from Terminal Value |
|---|---|---|---|
| 5-Year Growth | $45 | $550M | 72.9% |
| 10-Year Growth | $51 | $629M | 54.0% |
| 5-Year EBITDA | $83 | $1,070M | 86.1% |
| 10-Year EBITDA | $92 | $1,182M | 75.5% |
The DDM values a company based on its expected future dividend payments. We used two approaches:
EPV assesses a company's value based on its current normalized earnings power, assuming no growth.
| EPV Component | Value |
|---|---|
| Normalized Earnings | $32M |
| Discount Rate (WACC) | 8.9% - 5.9% |
| Enterprise Value | $361M - $547M |
| Net Debt | $(28)M |
| Equity Value | $389M - $575M |
| Outstanding Shares | 13M |
| Fair Value | $30 - $45 |
| Selected Fair Value | $37.35 |
| Metric | Value |
|---|---|
| Market Capitalization | $21M |
| Enterprise Value | $21M |
| Trailing P/E | 0.00 |
| Forward P/E | 0.60 |
| Trailing EV/EBITDA | 17.90 |
| Current Dividend Yield | 697.67% |
| Dividend Growth Rate (5Y) | 0.00% |
| Debt-to-Equity Ratio | 0.00 |
To determine the most reliable intrinsic value estimate, we weigh each valuation method based on:
| Valuation Method | Weight | Weighted Value |
|---|---|---|
| Discounted Cash Flow (10Y) | 30% | $15.29 |
| Discounted Cash Flow (5Y) | 25% | $11.20 |
| Dividend Discount Model (Multi-Stage) | 20% | $6.63 |
| Dividend Discount Model (Stable) | 15% | $4.79 |
| Earnings Power Value | 10% | $3.73 |
| Weighted Average | 100% | $41.64 |
Based on our comprehensive valuation analysis, Nanorepro AG's weighted average intrinsic value is $41.64, which is approximately 2423.6% above the current market price of $1.65.
Key investment considerations:
Given these factors, we believe Nanorepro AG is currently significantly undervalued with the potential for long-term appreciation based on the company's growth trajectory and financial strength.